1. Preface

   • B. E. C. Nordin
   • S. W. Stanbury

   EditorialNotes Pages: iii - iii

2. Erratum

   Erratum Pages: iv - iv

3. 1,25-Dihydroxyvitamin D₃: Mode of action in intestine and parathyroid glands, assay in humans and isolation of its glycoside fromSolanum malacoxylon

   • M. R. Haussler
   • M. R. Hughes
   • R. H. Wasserman

   Section I — Verbal Presentations Pages: 1 - 18

4. Responses of bone metabolism in the Eel (Anguilla anguilla) to injections of 1,25-dihydroxyvitamin D₃

   • E. Lopez
   • J. Peignoux-Deville
   • I. Macintyre

   Section I — Verbal Presentations Pages: 19 - 23

5. The use of an isolated perfused liver to study the control of cholecalciferol-25-hydroxylase activity in the rat

   • E. B. Mawer
   • A. Reeve

   Section I — Verbal Presentations Pages: 24 - 28

6. 25-Hydroxyvitamin D₃ regulation

   • M. B. Clark
   • J. T. Potts Jr.

   Section I — Verbal Presentations Pages: 29 - 34

7. Intestinal proteins synthesised in response to vitamin D

   • R. Spencer
   • D. E. M. Lawson
   • M. Charman

   Section I — Verbal Presentations Pages: 35 - 39

8. Competitive protein-binding assay for 24,25-dihydroxycholecalciferol

   • C. M. Taylor
   • P. de Silva
   • S. E. Hughes

   Section I — Verbal Presentations Pages: 40 - 44

9. Differences in duodenal calcium-binding protein (CaBP) in response to a low-calcium or a low-phosphorus intake

   • M. Thomasset
   • P. Cuisinier-Gleizes
   • H. Mathieu

   Section I — Verbal Presentations Pages: 45 - 50

10. The effects of dietary calcium and of oestrogen on the metabolism of 25-hydroxycholecalciferol in vitamin D-replete chicks

    • B. A. Sommerville
    • R. Swaminathan
    • C. G. Scanes

    Section I — Verbal Presentations Pages: 51 - 54

11. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1α-hydroxy vitaminD₃

    • M. Peacock
    • P. J. Heyburn
    • J. E. Aaron

    Section I — Verbal Presentations Pages: 55 - 62

12. Treatment of the rickets of cystinosis with 1-alpha-hydroxycholecalciferol

    • J. M. Gertner
    • D. P. Brenton
    • M. Domenech

    Section I — Verbal Presentations Pages: 63 - 67

13. Effects of 1,25-dihydroxycholecalciferol on calcium and phosphorus metabolism in hypoparathyroidism

    • M. Davies

    Section I — Verbal Presentations Pages: 68 - 73

14. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in osteoporosis

    • M. Davies
    • E. B. Mawer
    • P. H. Adams

    Section I — Verbal Presentations Pages: 74 - 77

15. The effect of 1α-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis

    • D. H. Marshall
    • J. C. Gallagher
    • B. E. C. Nordin

    Section I — Verbal Presentations Pages: 78 - 84

16. Serum ionized calcium in renal failure — a guideline for 1α-hydroxycholecalciferol treatment

    • S. Pors Nielsen
    • T. Falck Christiansen
    • O. H. Sørensen

    Section I — Verbal Presentations Pages: 85 - 93

17. Treatment of renal osteodystrophy with 1α-hydroxycholecalciferol (1α-OH-D₃) in conjunction with a high dialysate calcium

    • R. J. Winney
    • J. M. Bone
    • J. S. Robson

    Section I — Verbal Presentations Pages: 94 - 100

18. Controlled therapeutic trial of 1α-hydroxycholecalciferol in chronic renal failure

    • L. Tougaard
    • E. Sörensen
    • A. W. S. Sörensen

    Section I — Verbal Presentations Pages: 101 - 104

19. 1α-Hydroxycholecalciferol in renal osteodystrophy

    • A. M. Pierides
    • H. A. Ellis
    • D. N. S. Kerr

    Section I — Verbal Presentations Pages: 105 - 111

20. The treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol

    • B. J. R. Junor
    • G. R. D. Catto
    • M. Macleod

    Section I — Verbal Presentations Pages: 112 - 116

21. Receptors and cyclic nucleotides in secretion and action of parathyroid hormone

    • G. D. Aurbach
    • E. M. Brown
    • S. J. Marx

    Section I — Verbal Presentations Pages: 117 - 126

22. Double isotope estimates of intestinal calcium absorptio in rats: Enhancement by parathyroid hormone and 1,25-dihydroxycholecalciferol

    • J. A. Parsons
    • J. M. Zanelli
    • R. W. Stevenson

    Section I — Verbal Presentations Pages: 127 - 132

23. The role of parathyroid hormone in the adaptation of phosphate absorption from the jejunum of conscious pigs

    • J. Fox
    • R. Swaminathan
    • A. D. Care

    Section I — Verbal Presentations Pages: 133 - 136

24. The effect ofβ-blockade on ethanol-induced secretion of calcitonin in chronic renal failure

    • G. Heynen
    • M. Cecchettin
    • P. Franchimont

    Section I — Verbal Presentations Pages: 137 - 141

25. Physiological hyperparathyroidism in human lactation

    • R. W. Retallack
    • M. Jeffries
    • M. Smith

    Section I — Verbal Presentations Pages: 142 - 146

26. The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure

    • J. A. Kanis
    • M. Earnshaw
    • C. G. Woods

    Section I — Verbal Presentations Pages: 147 - 153

27. Calcitonin secretion in renal disease

    • J. C. Lee
    • J. G. Parthemore
    • L. J. Deftos

    Section I — Verbal Presentations Pages: 154 - 157

28. Studies on the stability of bPTH (1–84) and bPTH (1–34) receptor complexes by measuring the hormone-induced lactate fluxes of embryonic mouse calvariain vitro

    • M. P. M. Herrmann-Erlee
    • J. W. Hekkelman

    Section I — Verbal Presentations Pages: 158 - 163

29. Factors influencing the effect of parathyroid hormone on endosteal cell morphology. A scanning electron microscope study

    • B. Krempien
    • G. Friedrich
    • E. Ritz

    Section I — Verbal Presentations Pages: 164 - 168

30. Aerobic glycolysis in bone in the context of membrane-compartmentalization

    • W. F. Neuman

    Section I — Verbal Presentations Pages: 169 - 178

31. Initiation of mineral deposition in dentine

    • E. Katchburian

    Section I — Verbal Presentations Pages: 179 - 184

32. The fate of matrix proteins during the development of dental enamel

    • C. Robinson
    • P. Fuchs
    • J. A. Weatherell

    Section I — Verbal Presentations Pages: 185 - 190

33. Role of a Ca²⁺-binding glycoprotein in the calcification process

    • B. De Bernard
    • G. Furlan
    • M. Zanetti

    Section I — Verbal Presentations Pages: 191 - 196

34. In vitro nucleation of hydroxyapatite by a bone calcium-phospholipid-phosphate complex

    • A. L. Boskey
    • A. S. Posner

    Section I — Verbal Presentations Pages: 197 - 201

35. Biochemical effect of mechanical stress on cultured bone cells

    • A. Harell
    • S. Dekel
    • I. Binderman

    Section I — Verbal Presentations Pages: 202 - 207

36. Role of ATP and Mg in the stabilization of biological and synthetic amorphous calcium phosphates

    • A. S. Posner
    • F. Betts
    • N. C. Blumenthal

    Section I — Verbal Presentations Pages: 208 - 212

37. Endogenous oestrogen and bone loss following oophorectomy

    • R. Lindsay
    • D. M. Hart
    • A. Clarke

    Section I — Verbal Presentations Pages: 213 - 216

38. Observations of sequential changes in bone mass in postmenopausal women: a controlled trial of oestrogen and calcium therapy

    • A. Horsman
    • B. E. C. Nordin
    • M. Simpson

    Section I — Verbal Presentations Pages: 217 - 224

39. Changes in plasma steroids and bone density in Klinefelter's syndrome

    • D. A. S. Smith
    • M. S. Walker

    Section I — Verbal Presentations Pages: 225 - 228

40. Interrelationships between bone morphometry, thyroid function tests and serum parathyroid hormone in hyperthyroidism

    • L. Mosekilde
    • F. Melsen
    • M. S. Christensen

    Section I — Verbal Presentations Pages: 229 - 235

41. The use of sodium fluoride, vitamin D and calcium supplements in the treatment of patients with axial osteoporosis

    • V. Parsons
    • C. J. Mitchell
    • R. Hesp

    Section I — Verbal Presentations Pages: 236 - 240

42. Bone mineral estimation employing computer-assisted transverse axial tomography

    • I. Isherwood
    • R. A. Rutherford
    • P. H. Adams

    Section I — Verbal Presentations Pages: 241 - 241

43. Quantitative analysis of osteolytic versus osteoclastic activity in various experimental osteoporoses. 1. Disuse osteoporosis

    • G. Marotti
    • M. Ledda
    • M. Fadda

    Section I — Verbal Presentations Pages: 242 - 246

44. Autoclasis—a mechanism of bone resorption and an alternative explanation for osteoporosis

    • Jean E. Aaron

    Section I — Verbal Presentations Pages: 247 - 254

45. Bone cells and remodelling surfaces in acromegaly

    • G. R. Delling
    • A. Schulz

    Section I — Verbal Presentations Pages: 255 - 259

46. Reversibility of osteoporosis induced in adult rats by calcium deficiency. Long- and short-term observations

    • J. A. Sevastikoglou
    • V. Th. Thomaidis
    • T. S. Lindholm

    Section I — Verbal Presentations Pages: 260 - 265

47. The tooth and its bony support

    • P. -A. Henrikson

    Section I — Verbal Presentations Pages: 266 - 268

48. Cells cultured from human giant cell tumors of bone respond to parathyroid hormone

    • S. R. Goldring
    • J. -M. Dayer
    • S. M. Krane

    Section I — Verbal Presentations Pages: 269 - 274

49. Long-term culture of parathyroid hormone and prostaglandin E₁ responsive bone cells in monolayers and on artificial capillaries

    • J. N. M. Heersche
    • H. K. Moe
    • L. G. Rao

    Section I — Verbal Presentations Pages: 275 - 282

50. Is Paget's disease of bone a viral infection?

    • A. Rebel
    • K. Malkani
    • Ch. Bregeon

    Section I — Verbal Presentations Pages: 283 - 286